HeartSciences Inc. (HSCS)
NASDAQ: HSCS · Real-Time Price · USD
3.140
-0.350 (-10.03%)
Oct 8, 2026, 2:28 PM EDT - Market open
HeartSciences Revenue
HeartSciences had revenue of $2.10K in the quarter ending July 31, 2026, with 10.53% growth. This brings the company's revenue in the last twelve months to $4.52K, down -27.70% year-over-year. In the fiscal year ending April 30, 2026, HeartSciences had annual revenue of $4.32K, down -0.71%. That makes HeartSciences the 47,438th largest company in the world by revenue and 7,233rd in the United States.
Revenue (ttm)
$4.52K
Revenue Growth
-27.70%
P/S Ratio
3,707.15
Revenue / Employee
$323
Employees
14
Market Cap
15.07M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Apr 30, 2026 | 4.32K | -31.00 | -0.71% |
| Apr 30, 2025 | 4.35K | -14.25K | -76.61% |
| Apr 30, 2024 | 18.60K | 13.45K | 261.17% |
| Apr 30, 2023 | 5.15K | -9.22K | -64.17% |
| Apr 30, 2022 | 14.37K | -11.23K | -43.86% |
| Apr 30, 2021 | 25.60K | -38.58K | -60.11% |
| Apr 30, 2020 | 64.18K | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Accuray | 401.95M |
| IRIDEX | 51.57M |
| Cytosorbents | 37.22M |
| Lifeward | 21.82M |
| Pulsenmore | 14.13M |
| NeuroOne Medical Technologies | 12.47M |
| InspireMD | 10.84M |
| Picard Medical | 6.30M |
HSCS News
- 2 days ago - HeartSciences gets FDA clearance for MyoVista wavECG device - TheFly
- 2 days ago - HeartSciences Receives FDA 510(k) Clearance for its MyoVista® wavECGTM Device - GlobeNewsWire
- 2 days ago - HeartSciences Proxy statement: Proxy filing - Filings
- 2 days ago - HeartSciences Proxy statement: Proxy filing - Filings
- 2 days ago - HeartSciences Proxy statement: Proxy filing - Filings
- 6 days ago - HeartSciences Proxy statement: Proxy filing - Filings
- 8 days ago - HeartSciences Proxy statement: Proxy filing - Filings
- 8 days ago - Fortitude Appoints Kimberly Pittman as Chief Legal Officer - Business Wire